Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Farrell

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Gastroenterology and Hepatology|June 9, 2020
Relationship between papilla-related variables and post endoscopic retrograde cholangiopancreatography pancreatitis: A multicenter, prospective studyXiangping Wang, Jianghai Zhao, Limei Wang, et al.
Gastroenterology|November 11, 2008
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancerJames J Farrell, Hany Elsaleh, Miguel Garcia, et al.
Pancreas|December 24, 2010
Intraobserver agreement among endosonographers for endoscopic ultrasound features of chronic pancreatitis: a blinded multicenter studyJohn G Lieb, David T Palma, Cynthia W Garvan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2014
Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancerAndrew H Nguyen, Paul A Toste, James J Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
Integrative survival-based molecular profiling of human pancreatic cancerTimothy R Donahue, Linh M Tran, Reginald Hill, et al.
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
United European Gastroenterology Journal|February 24, 2022
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progressionKasper A Overbeek, Nikki van Leeuwen, Matteo Tacelli, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 1, 2023
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer SurveillanceBryson W Katona, Kelsey Klute, Randall E Brand, et al.
Pancreas|December 3, 2021
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerLee Ying, Anup Sharma, Ankit Chhoda, et al.
Gastrointestinal Endoscopy|January 18, 2012
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyJ Randolph Hecht, James J Farrell, Neil Senzer, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology and Hepatology|June 9, 2020
Relationship between papilla-related variables and post endoscopic retrograde cholangiopancreatography pancreatitis: A multicenter, prospective studyXiangping Wang, Jianghai Zhao, Limei Wang, et al.
Gastroenterology|November 11, 2008
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancerJames J Farrell, Hany Elsaleh, Miguel Garcia, et al.
Pancreas|December 24, 2010
Intraobserver agreement among endosonographers for endoscopic ultrasound features of chronic pancreatitis: a blinded multicenter studyJohn G Lieb, David T Palma, Cynthia W Garvan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2014
Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancerAndrew H Nguyen, Paul A Toste, James J Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
Integrative survival-based molecular profiling of human pancreatic cancerTimothy R Donahue, Linh M Tran, Reginald Hill, et al.
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
United European Gastroenterology Journal|February 24, 2022
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progressionKasper A Overbeek, Nikki van Leeuwen, Matteo Tacelli, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 1, 2023
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer SurveillanceBryson W Katona, Kelsey Klute, Randall E Brand, et al.
Pancreas|December 3, 2021
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerLee Ying, Anup Sharma, Ankit Chhoda, et al.
Gastrointestinal Endoscopy|January 18, 2012
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyJ Randolph Hecht, James J Farrell, Neil Senzer, et al.
Pageof 9